Ann: Imagion Biosystems December 2021 Investor Newsletter, page-52

The more disparity in the voices here, the better the input for any independent critical thinking.
Emotionally presented opinions will elicit emotionally charged responses, and if kept relatively
decent, then everyone will add to the forum.

I value most perspectives here even though I don't always agree with them - It's less about being
proven right or wrong (IMO) than it is to continually challenge our perspectives and share our
insights because the market is made up of many types of investors, with differing investment
timeframes. Thankfully so! If we all saw it one way and one way only, there would be no market.

No doubt we have seen delayed traction with our trial but as long as lessons are learned courses
are corrected and progress is made I don't mind. Potential now has to materially translate to results,
and I'm comfortable that we will make significant headway from here on. If for any reason we don't
make progress, I will reassess as to whether the LT goal is conceivable and plausible and act
accordingly, (for me) I believe we're now back on track to achieve the Co goals.

I recognise that others may use a different prism and have a different timeframe and in the end, I
hope we all do well.